EBQ:Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack: Difference between revisions
No edit summary |
(Completed all empty sections) |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{JC info | |||
| title= Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack | |||
| abbreviation= | |||
| expansion= | |||
| published= 2007 | |||
| author= Johnston S. et al. | |||
| journal= Lancet | |||
| year= 2007 | |||
| volume= 369: | |||
| issue=9558 | |||
| pages= 283-9 | |||
| pmid= 17258668 | |||
| fulltexturl= http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60150-0/fulltext | |||
| pdfurl= http://emjournalclub.com/uploads/ABCD2_Lancet.pdf | |||
| status = Complete | |||
}} | |||
==Clinical Question== | |||
Aims: To validate two prognostic scores for early risk of stroke after TIA and to derive and validate a unified score optimized for prediction of 2-day stroke risk to inform emergency management | |||
==Conclusion== | |||
*The ABCD2 score (combining elements of the ABCD and California scores) predicts stroke risk within 2, 7, and 90 days after TIA | |||
*Higher ABCD2 scores correlate with increased short-term stroke risk | |||
*Scores >=4 identify patients at highest risk who warrant urgent evaluation and admission | |||
==Major Points== | |||
*The ABCD2 score unified two existing prediction tools (ABCD and California) into a single validated instrument | |||
*Score components: Age >=60 (1pt), BP >=140/90 (1pt), Clinical features - unilateral weakness (2pt) or speech impairment without weakness (1pt), Duration >=60min (2pt) or 10-59min (1pt), Diabetes (1pt) | |||
*2-day stroke risk by score: 0-3 (low) 1.0%, 4-5 (moderate) 4.1%, 6-7 (high) 8.1% | |||
*The score performs better than either predecessor alone for stroke risk stratification | |||
*Widely adopted in emergency medicine for TIA risk stratification and disposition decisions | |||
==Study Design== | |||
*Retrospective validation study using pooled data from existing cohorts | |||
*Derivation cohort: 1,916 TIA patients from Oxfordshire, UK | |||
*Validation cohorts: 2,893 patients from California and 1,891 from additional UK sites | |||
*Primary Outcome: stroke within 2, 7, and 90 days of TIA | |||
==Population== | |||
===Inclusion Criteria=== | |||
*Patients diagnosed with TIA by treating physician or neurologist | |||
*Sufficient clinical data to calculate ABCD2 score | |||
===Exclusion Criteria=== | |||
*Patients with stroke rather than TIA at presentation | |||
*Insufficient follow-up data | |||
===Patient Demographics=== | |||
===Inclusion Criteria=== | |||
===Exclusion Criteria=== | |||
==Interventions== | |||
*No therapeutic intervention; this was a predictive score derivation and validation study | |||
*ABCD2 score calculated retrospectively from recorded clinical data | |||
*Stroke outcomes ascertained through chart review and follow-up | |||
==Outcomes== | |||
===Primary Outcome=== | |||
*Stroke within 2 days by ABCD2 score: | |||
**Score 0-3: 1.0% | |||
**Score 4-5: 4.1% | |||
**Score 6-7: 8.1% | |||
===Secondary Outcomes=== | |||
*7-day stroke risk: 1.2% (low), 5.9% (moderate), 11.7% (high) | |||
*90-day stroke risk: 3.1% (low), 9.8% (moderate), 17.8% (high) | |||
*C-statistic for 7-day risk: 0.72 (validation cohort) | |||
===Primary Outcome=== | |||
===Secondary Outcomes=== | |||
===Subgroup analysis=== | |||
==Criticisms & Further Discussion== | |||
==Funding== | |||
*UK Medical Research Council | |||
*Wellcome Trust | |||
==Sources== | |||
<references/> | |||
[[Category:EBQ]] | [[Category:EBQ]] | ||
[[Category:Neurology]] | |||
Latest revision as of 22:52, 21 March 2026
Complete Journal Club Article
Johnston S. et al.. "Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack". Lancet. 2007. 369:(9558):283-9.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Aims: To validate two prognostic scores for early risk of stroke after TIA and to derive and validate a unified score optimized for prediction of 2-day stroke risk to inform emergency management
Conclusion
- The ABCD2 score (combining elements of the ABCD and California scores) predicts stroke risk within 2, 7, and 90 days after TIA
- Higher ABCD2 scores correlate with increased short-term stroke risk
- Scores >=4 identify patients at highest risk who warrant urgent evaluation and admission
Major Points
- The ABCD2 score unified two existing prediction tools (ABCD and California) into a single validated instrument
- Score components: Age >=60 (1pt), BP >=140/90 (1pt), Clinical features - unilateral weakness (2pt) or speech impairment without weakness (1pt), Duration >=60min (2pt) or 10-59min (1pt), Diabetes (1pt)
- 2-day stroke risk by score: 0-3 (low) 1.0%, 4-5 (moderate) 4.1%, 6-7 (high) 8.1%
- The score performs better than either predecessor alone for stroke risk stratification
- Widely adopted in emergency medicine for TIA risk stratification and disposition decisions
Study Design
- Retrospective validation study using pooled data from existing cohorts
- Derivation cohort: 1,916 TIA patients from Oxfordshire, UK
- Validation cohorts: 2,893 patients from California and 1,891 from additional UK sites
- Primary Outcome: stroke within 2, 7, and 90 days of TIA
Population
Inclusion Criteria
- Patients diagnosed with TIA by treating physician or neurologist
- Sufficient clinical data to calculate ABCD2 score
Exclusion Criteria
- Patients with stroke rather than TIA at presentation
- Insufficient follow-up data
Patient Demographics
Inclusion Criteria
Exclusion Criteria
Interventions
- No therapeutic intervention; this was a predictive score derivation and validation study
- ABCD2 score calculated retrospectively from recorded clinical data
- Stroke outcomes ascertained through chart review and follow-up
Outcomes
Primary Outcome
- Stroke within 2 days by ABCD2 score:
- Score 0-3: 1.0%
- Score 4-5: 4.1%
- Score 6-7: 8.1%
Secondary Outcomes
- 7-day stroke risk: 1.2% (low), 5.9% (moderate), 11.7% (high)
- 90-day stroke risk: 3.1% (low), 9.8% (moderate), 17.8% (high)
- C-statistic for 7-day risk: 0.72 (validation cohort)
Primary Outcome
Secondary Outcomes
Subgroup analysis
Criticisms & Further Discussion
Funding
- UK Medical Research Council
- Wellcome Trust
